Article Name Medtech
Led by aMoon, the round fuels development of advanced GI diagnostics and supports global rollout of MAGENTIQ-COLO™, the FDA- and CE-cleared solution enhancing real-time polyp detection and analysis during colonoscopy procedures.
31st July, 2025
Equipped with ISO Class 7 cleanrooms and expanded R&D capacity, the new site accelerates Galaxy’s path to commercial readiness and global distribution of its breakthrough neurovascular technologies.
31st July, 2025
VersaCoat, a syringe-deliverable soft-tissue protector, brings Alafair’s proven hyaluronic acid and alginate formula to complex surgical sites—expanding its impact in orthopedic, trauma, and sports medicine procedures.
31st July, 2025
With total federal support exceeding $52M, RIVANNA accelerates development of CADe/x — an AI-driven diagnostic tool poised to transform musculoskeletal care through automated ultrasound image analysis and real-time fracture triage.
31st July, 2025
Strategic collaboration aims to accelerate validation and commercialisation of non-invasive tests, enabling earlier, more accessible diagnosis of Alzheimer’s disease
30th July, 2025
Strategic relocation from Hong Kong strengthens ties to Asia’s thriving MedTech ecosystem, enhances collaboration with global partners, and supports ambitious expansion plans
30th July, 2025
AI-powered, patient-matched solution aims to simplify Lapidus procedures and enhance surgical outcomes
30th July, 2025
Partnership aims for CAP/CLIA certification of organoid-based assay to guide patient-specific treatment decisions; $10 million investment to fuel clinical validation across multiple cancer types
30th July, 2025
By aligning regulatory rigour with technological complexity, the FDA safeguards public health while accelerating access to life-changing medical innovations through adaptive pathways and total lifecycle vigilance
30th July, 2025
First and only purpose-built solution delivering rapid and complete luminal clot removal in small vessel and arteriovenous access cases
30th July, 2025
First in the industry to achieve dual certification for both reagents and analysers within its Atellica portfolio
30th July, 2025
Developed with PacBio's PureTarget technology, the new test enhances identification of complex DNA repeat expansions to support accurate diagnosis and care for patients with neurological disorders
30th July, 2025
Strategic alliance enhances in-home screening with advanced molecular diagnostics, AI-driven insights, and flexible testing options to improve outcomes for patients and underserved communities.
29th July, 2025
Designed for seamless remote use, the ‘Anywhere powered by Linus Health™’ platform brings early detection of cognitive decline to payers, pharma, wellness providers, and consumers—anytime, anywhere.
29th July, 2025
Breakthrough findings for QyScore® and QyPredict® highlight enhanced accuracy in brain segmentation and early identification of cognitive decline, paving the way for improved clinical trials and patient outcomes in Alzheimer’s disease.
29th July, 2025
Vinmec Central Park pioneers breakthrough treatment using AutoGuide™ system, offering new hope for children with drug-resistant epilepsy and marking a significant leap towards global neurological care standards.
29th July, 2025
Global trials confirm device's accuracy and potential to reshape chronic disease management
24th June, 2025
Six-month safety and effectiveness data for the 250 randomized patients to support PMA submission to FDA; enrollment to continue to 400
24th June, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer